Global Financial Private Client’s BioNTech BNTX Stock Holding History

Global Financial Private Client’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-100	Closed	-$10.6K	–	704
2023 Q4	$10.6K	Hold	100	–	–	﹤0.01%	452
2023 Q3	$11.3K	Hold	100	–	–	0.01%	421
2023 Q2	$10.8K	Hold	100	–	–	0.01%	427
2023 Q1	$13K	Hold	100	–	–	0.01%	419
2022 Q4	$15K	Hold	100	–	–	0.01%	380
2022 Q3	$13.7K	Hold	100	–	–	0.01%	382
2022 Q2	$15.8K	Hold	100	–	–	0.01%	362
2022 Q1	$17.9K	Hold	100	–	–	0.01%	356
2021 Q4	$25.8K	Hold	100	–	–	0.01%	318
2021 Q3	$25.5K	Hold	100	–	–	0.01%	293
2021 Q2	$22.4K	Hold	100	–	–	0.01%	304
2021 Q1	$11.4K	Hold	100	–	–	0.01%	306
2020 Q4	$8.15K	Hold	100	–	–	0.01%	318
2020 Q3	$7.27K	Buy	+100	New	+$7.17K	0.01%	323

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Global Financial Private Client's BNTX Position: Q1 2024 in Review

Global Financial Private Client sold out of BioNTech (BNTX) in Q1 2024, closing a stake of 100 shares — an estimated $10.6K sold.

Global Financial Private Client first reported a position in BNTX in Q3 2020 and held it in 14 quarters. The position peaked at $25.8K in Q4 2021. 287 funds tracked by Wall St. Rank hold BNTX as of Q1 2024.

Global Financial Private Client reported no remaining BioNTech position as of Q1 2024 after selling out during the quarter.
Global Financial Private Client sold 100 BioNTech shares in Q1 2024, an estimated $10.6K.
Global Financial Private Client first reported a position in BioNTech in Q3 2020 and held it in 14 quarters.
Global Financial Private Client's BioNTech position peaked at $25.8K in Q4 2021.
287 funds tracked by Wall St. Rank held BioNTech as of Q1 2024.

Based on Global Financial Private Client's 13F filing for Q1 2024, filed 16 May 2024.